Article Text

Download PDFPDF
CASE REPORT
Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary
  1. Rupal Dosi,
  2. Annirudh Ambaliya,
  3. Harshal Joshi,
  4. Rushad Patell
  1. Department of Medicine, Medical College Baroda, Vadodara, Gujarat, India
  1. Correspondence to Dr Rushad Patell, rushadpatell{at}gmail.com

Summary

Serotonin syndrome and neuroleptic malignant syndrome are two drug toxidromes that have often overlapping and confusing clinical pictures. We report a case of a young man who presented with alteration of mental status, autonomic instability and neuromuscular hyperexcitability following ingestion of multiple psychiatric and antiepileptic medications. The patient satisfied criteria for serotonin syndrome and neuroleptic malignant syndrome, and based on the characteristic clinical features, laboratory findings and clinical course it was concluded that the patient had both toxidromes. The patient was managed with cyproheptadine and supportive measures, and recovered over the course of 3 weeks. A brief review of literature highlighting the diagnostic clues as well as the importance of recognising and distinguishing the often missed and confounding diagnoses follows.

View Full Text

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.